Ifp Advisors, Inc Clearside Biomedical, Inc. Put Options Transaction History
Ifp Advisors, Inc
- $3.07 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding CLSD
# of Institutions
50Shares Held
11MCall Options Held
5.9KPut Options Held
86.6K-
Vanguard Group Inc Valley Forge, PA2.81MShares$2.47 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$1.93 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$1.33 Million0.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$702,3600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA792KShares$697,1770.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $53M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...